Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Troponin in Non-ischaemic Dilated Cardiomyopathy
Author(s): Andrea Barison , Luigi Emilio Pastormerlo , Alberto Giannoni Added: 3 years ago
Among the various cardiovascular diseases, non-ischaemic dilated cardiomyopathy (DCM) represents a major cause of morbidity and mortality.1 DCM is characterised by the presence of left ventricular dilatation and systolic dysfunction in the absence of coronary artery disease or abnormal loading conditions (hypertension, valvular disease).2 It originates from several aetiologies and includes… View more

Heart Failure
Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
Author(s): Maki Komiyama , Koji Hasegawa , Akira Matsumori Added: 3 years ago
The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a public health emergency of international concern.1 The pandemic is ongoing, and the world is faced with the urgent task of minimising the mortality associated with COVID-19. Besides advanced age, risk factors for escalation of COVID-19 severity include underlying… View more

COVID-19
Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
Author(s): Alexandros Protonotarios , Perry Elliott Added: 3 years ago
Until the 20th century, conventional medicine relied almost exclusively on observable characteristics to classify and treat human disease.1 Even in the modern era, physicians define diseases using phenotypic similarities and employ relatively simple algorithms to interpret diagnostic tools and plan treatment. The advent of low-cost genetic sequencing and its introduction into clinical care… View more

Heart Failure
Author(s): Gianfranco Sinagra , Michele Moretti , Giancarlo Vitrella , et al Added: 3 years ago
According to the latest position statement of the European Society of Cardiology (ESC), cardiomyopathies (CMP) are defined as “myocardial disorders in which the heart muscle is structurally and functionally abnormal, in the absence of coronary artery disease, hypertension, valvular disease and congenital heart disease sufficient to cause the observed myocardial abnormality”.1 CMP may be… View more

Imaging & Diagnostics

Heart Failure
Author(s): Douglas Ewan Cannie , Mohammed Majid Akhtar , Perry Elliott Added: 3 years ago
Heart failure is a global health challenge, affecting 1–2% of the population and up to an estimated 64 million people worldwide.1,2 In the UK, just under 1 million people have heart failure, with approximately 350 new diagnoses each year per 100,000 population.3 The lifetime risk of developing heart failure at 55 years of age is 33% for men and 28% for women.4 The heart failure population is… View more

Heart Failure
Author(s): Mark M Boogers , Frank M Bengel , Juhani Knuuti , et al Added: 3 years ago
Chronic heart failure (HF) is an important healthcare problem in the developed world, since incidence and prevalence numbers have increased rapidly over recent decades. Recently, the American Heart Association (AHA) Statistics Committee and Stroke Statistics Committee reported that chronic HF affects 5.3 million patients in the US, with approximately 660,000 newly diagnosed patients each year.1… View more

Imaging & Diagnostics

Heart Failure
AHA 2018: TRED-HF Trial
Author(s): Brian Halliday Added: 5 years ago
Dr Brian Halliday (Imperial College London, UK) discusses TRED-HF - Withdrawal of pharmacological heart failure therapy in recovered dilated cardiomyopathy. Filmed by Radcliffe Cardiology on site at AHA 2018. View more

Heart Failure
Alcohol and Heart Failure
Author(s): Debar Rasoul , Ashwin Ajay , Alend Abdullah , et al Added: 3 months ago

Heart Failure
Carina Blomström-Lundqvist
Research Area(s) / Expertise: Job title: Professor of Cardiology
Dr Carina Blomström-Lundqvist is Professor of Cardiology at the Department of Cardiology, Institution of Medical Science, Uppsala, SE and Senior Consultant and Professor at the Department of Cardiology and Medical Science, Örebro University Hospital, Örebro, SE. Dr Blomström-Lundqvist graduated in medicine in 1976, she went on to specialise in cardiology and internal medicine, and started… View more
Author(s): Ottavio Alfieri , Michele De Bonis Added: 3 years ago
Despite the absence of randomised comparison, it is widely accepted that, when feasible, valve repair is the optimal surgical treatment in patients with severe degenerative mitral regurgitation (MR) due to the well documented advantages of such an approach over valve replacement in terms of perioperative mortality, preservation of postoperative left ventricular (LV) function and long-term… View more

Vascular Disease and Surgery

MI/ACS